2026 NPPES data Neuromuscular Medicine (Psychiatry & Neurology) Physician NPI 1932144573 M.D.
Verify on CMS →

MAZEN DIMACHKIE, M.D.

Neuromuscular Medicine (Psychiatry & Neurology) Physician in KANSAS CITY, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
620
Medicare Part D claims · 77 beneficiaries · Neuromuscular Medicine (Psychiatry & Neurology) Physician avg: 931
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.8902/100
▲ 9 pts above national avg 83.1 · [object Object]
Industry payments
$75.8K
27 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MAZEN DIMACHKIE, M.D. is a Neuromuscular Medicine (Psychiatry & Neurology) Physician ([object Object]) practicing in KANSAS CITY, Kansas with a Medicare Part D prescribing footprint of 620 claims across 77 beneficiaries — 24% brand-name prescribing . Their CMS MIPS Final Score of 91.8902/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $75.8K across 27 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MAZEN DIMACHKIE, M.D. reported a CMS MIPS final score of 91.8902 out of 100, above the 83.1 national average, and filed 620 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MAZEN DIMACHKIE, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MAZEN DIMACHKIE, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 06/18/2006

NPI 1932144573

Primary specialty

Neuromuscular Medicine (Psychiatry & Neurology) Physician

Rare

336 US NPIs in this specialty

Medicare Part D claims

620 33% vs specialty avg

2023 prescription claims

Specialty avg: 931

MIPS final score

91.8902/100 8.790199999999999% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Kansas

How Neuromuscular Medicine (Psychiatry & Neurology) Physician compares to other specialties among Kansas providers

Kansas providers

Neuromuscular Medicine (Psychiatry & Neurology) Physician share within Kansas

1. Neuromuscular Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neuromuscular Medicine (Psychiatry & Neurology) Physician share within Kansas

Medicare quality performance — MIPS

MAZEN DIMACHKIE, M.D.'s 2023 MIPS final score plotted against the Neuromuscular Medicine (Psychiatry & Neurology) Physician national average

High performer (top quartile)
MIPS Final Score
91.8902/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Neuromuscular Medicine (Psychiatry & Neurology) Physician) — 91.8902/100 vs national avg 83.1

0%100%National avg83%91.9%
MIPS final score (Neuromuscular Medicine (Psychiatry & Neurology) Physician) — 91.8902/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MAZEN DIMACHKIE, M.D. is a Neuromuscular Medicine (Psychiatry & Neurology) Physician provider practicing in KANSAS CITY, Kansas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1932144573. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MAZEN DIMACHKIE, M.D. appears in the CMS NPPES registry as a Neuromuscular Medicine (Psychiatry & Neurology) Physician provider holding M.D. credentials at 3599 RAINBOW BLVD # MS 2012, KANSAS CITY, KS, 66103, with a listed phone of (913) 588-6970. NPI 1932144573 was issued on 06/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DIMACHKIE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 620 prescription claims written by this provider, covering 77 Medicare beneficiaries and totaling roughly $3.2 million in drug spend, split 24% brand-name and 76% generic by claim count, with an opioid prescribing rate of 2.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.8902/100 for the 2023 performance year (Quality 75.1734), compared with the national average of 83.1.

Neuromuscular Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 336 enrolled providers across 44 states and an average of 931 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3599 RAINBOW BLVD # MS 2012
KANSAS CITY, KS 66103

Provider Details

NPI 1932144573
Specialty Neuromuscular Medicine (Psychiatry & Neurology) Physician
Credentials M.D.
Gender Male
NPI Issued 06/18/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.8902
Final Score
Avg: 83.1
75.1734
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where MAZEN DIMACHKIE, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

KANSAS UNIVERSITY PHYSICIANS INC
LENEXA, KS

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MAZEN DIMACHKIE, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$75.8K

Largest payer

Octapharma USA, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MAZEN DIMACHKIE, M.D. — brand share 24.0%
Specialty average (est.)

24% brand-name claims vs 76% generic, on 620 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

620
Total Claims
$3.2M
Total Drug Cost
77
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,221
Total Day Supply
35,698
Brand vs Generic
24% brand / 76% generic
Brand Drug Cost
$3.1M
Generic Drug Cost
$36K
Opioid Claims
14 (2.3% rate)
Antibiotic Claims
13

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
2.03
Gender Split
38% female / 62% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Prednisone
128
Pyridostigmine Bromide
77
Gammagard Liquid
Immun Glob G(Igg)/Gly/Iga Ov50
60
Gabapentin
51
Mycophenolate Mofetil
32
Sodium Chloride
0.9 % Sodium Chloride
32
Firdapse
Amifampridine Phosphate
28
Azathioprine
20
Pregabalin
18
Ultomiris
Ravulizumab-Cwvz
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neuromuscular Medicine (Psychiatry & Neurology) Physician Overview

How MAZEN DIMACHKIE, M.D. fits within the Neuromuscular Medicine (Psychiatry & Neurology) Physician landscape nationally.

336
Neuromuscular Medicine (Psychiatry & Neurology) Physician Providers in US
44
States with Neuromuscular Medicine (Psychiatry & Neurology) Physician
931
Avg Claims per Provider

MAZEN DIMACHKIE, M.D.'s 620 claims are below the specialty average of 931.

Nearby Neuromuscular Medicine (Psychiatry & Neurology) Physician Providers in Kansas

Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as DIMACHKIE.

Compare Neuromuscular Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MAZEN DIMACHKIE, M.D.'s specialty?
MAZEN DIMACHKIE, M.D. specializes in Neuromuscular Medicine (Psychiatry & Neurology) Physician and practices in KANSAS CITY, Kansas. Credentials: M.D..
How much does MAZEN DIMACHKIE, M.D. prescribe under Medicare Part D?
In 2023, MAZEN DIMACHKIE, M.D. wrote 620 Medicare Part D claims totaling $3.2M in drug costs for 77 beneficiaries.
What is MAZEN DIMACHKIE, M.D.'s Medicare quality score?
MAZEN DIMACHKIE, M.D. has a CMS MIPS Final Score of 91.8902/100 (Quality: 75.1734). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MAZEN DIMACHKIE, M.D. located?
MAZEN DIMACHKIE, M.D. is located at 3599 RAINBOW BLVD # MS 2012, KANSAS CITY, KS, 66103. Phone: (913) 588-6970.
What is MAZEN DIMACHKIE, M.D.'s NPI number?
MAZEN DIMACHKIE, M.D.'s National Provider Identifier (NPI) is 1932144573, issued on 06/18/2006.
Does MAZEN DIMACHKIE, M.D. prescribe more brand-name or generic drugs?
MAZEN DIMACHKIE, M.D.'s prescribing is 24% brand-name and 76% generic drugs by claim count, with $3.1M in brand drug costs.
Does MAZEN DIMACHKIE, M.D. prescribe opioids?
Yes, MAZEN DIMACHKIE, M.D. had 14 opioid claims in 2023 with an opioid prescribing rate of 2.3%.
How many Neuromuscular Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 336 Neuromuscular Medicine (Psychiatry & Neurology) Physician providers across 44 states in the US. The average Neuromuscular Medicine (Psychiatry & Neurology) Physician provider writes 931 Medicare Part D claims per year.
What drugs does MAZEN DIMACHKIE, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MAZEN DIMACHKIE, M.D.'s most frequently prescribed drugs include Prednisone, Pyridostigmine Bromide, Gammagard Liquid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MAZEN DIMACHKIE, M.D. accept Medicare?
MAZEN DIMACHKIE, M.D. appears in CMS Medicare data with 620 Part D claims and 77 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MAZEN DIMACHKIE, M.D.'s credentials?
MAZEN DIMACHKIE, M.D.'s NPI is 1932144573 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology